{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:01:15Z","timestamp":1773079275604,"version":"3.50.1"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.trsl.2019.08.003","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T11:40:18Z","timestamp":1565610018000},"page":"75-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Atherothrombosis and the NLRP3 inflammasome \u2013 endogenous mechanisms of inhibition"],"prefix":"10.1016","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3567-8877","authenticated-orcid":false,"given":"Mohan","family":"Satish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5445-0013","authenticated-orcid":false,"given":"Devendra K.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2019.08.003_bib0001","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.003_bib0002","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.08.003_bib0003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.003_bib0004","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.003_bib0005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Anti-inflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.003_bib0006","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1\u03b2 decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0007","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1172\/JCI118476","article-title":"Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor","volume":"97","author":"Shimokawa","year":"1996","journal-title":"J Clin Invest."},{"key":"10.1016\/j.trsl.2019.08.003_bib0008","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1161\/CIRCULATIONAHA.115.016160","article-title":"Targeting interleukin-1\u03b2 reduces leukocyte production after acute myocardial infarction","volume":"132","author":"Sager","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2019.08.003_bib0009","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1093\/eurheartj\/ehy310","article-title":"Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"39","author":"Ridker","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.trsl.2019.08.003_bib0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.trsl.2019.08.003_bib0011","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","author":"Swerdlow","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2019.08.003_bib0012","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies","volume":"379","author":"Sarwar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2019.08.003_bib0013","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.trsl.2019.08.003_bib0014","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From CRP to IL-6 to IL-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res."},{"key":"10.1016\/j.trsl.2019.08.003_bib0015","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals [published correction appears in Nature. 2010 Jul 29;466(7306):652]","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.08.003_bib0016","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.115.304437","article-title":"Moderate hypoxia potentiates interleukin-1\u03b2 production in activated human macrophages","volume":"115","author":"Folco","year":"2014","journal-title":"Circ Res."},{"key":"10.1016\/j.trsl.2019.08.003_bib0017","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCULATIONAHA.113.002714","article-title":"Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility","volume":"128","author":"Xiao","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2019.08.003_bib0018","doi-asserted-by":"crossref","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.08.003_bib0019","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1083\/jcb.201602089","article-title":"The cell biology of inflammasomes: mechanisms of inflammasome activation and regulation","volume":"213","author":"Sharma","year":"2016","journal-title":"J Cell Biol."},{"key":"10.1016\/j.trsl.2019.08.003_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nri.2015.7","article-title":"Converging roles of caspases in inflammasome activation, cell death and innate immunity","volume":"16","author":"Man","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.trsl.2019.08.003_bib0021","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.1184003","article-title":"The NLRP3 inflammasome: a sensor for metabolic danger?","volume":"327","author":"Schroder","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.trsl.2019.08.003_bib0022","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ni.3333","article-title":"NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component","volume":"17","author":"Shi","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0023","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat Med."},{"key":"10.1016\/j.trsl.2019.08.003_bib0024","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1084\/jem.20162040","article-title":"Protein kinase D at the Golgi controls NLRP3 inflammasome activation","volume":"214","author":"Zhang","year":"2017","journal-title":"J Exp Med."},{"key":"10.1016\/j.trsl.2019.08.003_bib0025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J Immunol."},{"key":"10.1016\/j.trsl.2019.08.003_bib0026","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/intimm\/dxx018","article-title":"Mechanisms governing inflammasome activation, assembly and pyroptosis induction","volume":"29","author":"Kesavardhana","year":"2017","journal-title":"Int Immunol."},{"key":"10.1016\/j.trsl.2019.08.003_bib0027","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.08.003_bib0028","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.08.003_bib0029","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.jacc.2017.09.028","article-title":"Interleukin-1 beta as a target for atherosclerosis therapy","volume":"70","author":"Libby","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0030","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1073\/pnas.83.12.4533","article-title":"Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1","volume":"83","author":"Bevilacqua","year":"1986","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.trsl.2019.08.003_bib0031","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1172\/JCI113346","article-title":"Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids","volume":"81","author":"Libby","year":"1988","journal-title":"J Clin Invest."},{"key":"10.1016\/j.trsl.2019.08.003_bib0032","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.ATV.0000147126.99529.0a","article-title":"Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E\u2013deficient mice","volume":"24","author":"Nooijer","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0033","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/01.ATV.0000153516.02782.65","article-title":"IL-18 accelerates atherosclerosis accompanied by elevation of IFN-\u03b3 and CXCL16 expression independently of T cells","volume":"25","author":"Tenger","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0034","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.trsl.2019.08.003_bib0035","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ Res."},{"key":"10.1016\/j.trsl.2019.08.003_bib0036","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.110.207415","article-title":"Recent advances on the role of cytokines in atherosclerosis","volume":"31","author":"Ait-Oufella","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.trsl.2019.08.003_bib0037","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvn120","article-title":"Cytokines and atherosclerosis: a comprehensive review of studies in mice","volume":"79","author":"Kleemann","year":"2008","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.trsl.2019.08.003_bib0038","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals [published correction appears in Nature. 2010 Jul 29;466(7306):652]","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.08.003_bib0039","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat Immunol."},{"key":"10.1016\/j.trsl.2019.08.003_bib0040","doi-asserted-by":"crossref","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajamaki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.08.003_bib0041","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5551\/jat.RV17001","article-title":"Role of NLRP3 inflammasomes in atherosclerosis","volume":"24","author":"Karasawa","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.trsl.2019.08.003_bib0042","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2012.07.058","article-title":"Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice","volume":"425","author":"Usui","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2019.08.003_bib0043","first-page":"222","article-title":"Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice","volume":"28","author":"Gage","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0044","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1111\/febs.13279","article-title":"Bone marrow-specific caspase-1\/11 deficiency inhibits atherosclerosis development in Ldlr\u2212\/\u2212mice","volume":"282","author":"Hendrikx","year":"2015","journal-title":"FEBS J"},{"key":"10.1016\/j.trsl.2019.08.003_bib0045","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/ATVBAHA.117.310581","article-title":"Saturated fatty acids undergo intracellular crystallization and activate the NLRP3 inflammasome in macrophages","volume":"38","author":"Karasawa","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0046","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCRESAHA.118.313129","article-title":"Anticytokine agents","volume":"124","author":"Ridker","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2019.08.003_bib0047","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.08.003_bib0048","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2353\/ajpath.2010.091082","article-title":"Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis","volume":"177","author":"Ho","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0049","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1096\/fj.201500155R","article-title":"Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling","volume":"30","author":"Elajami","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2019.08.003_bib0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/14779072.2019.1563483","article-title":"Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases","volume":"17","author":"Satish","year":"2019","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.trsl.2019.08.003_bib0051","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2019.08.003_bib0052","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCRESAHA.116.309794","article-title":"Proresolving lipid mediators restore balance to the vulnerable plaque","volume":"119","author":"Thorp","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2019.08.003_bib0053","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1096\/fj.08-112201","article-title":"Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators","volume":"22","author":"Merched","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2019.08.003_bib0054","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1073\/pnas.2133253100","article-title":"Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity","volume":"100","author":"Luo","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.trsl.2019.08.003_bib0055","doi-asserted-by":"crossref","first-page":"14530","DOI":"10.1073\/pnas.1410851111","article-title":"Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4synthesis by inhibiting a calcium-activated kinase pathway","volume":"111","author":"Fredman","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.trsl.2019.08.003_bib0056","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1073\/pnas.1524292113","article-title":"MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation","volume":"113","author":"Cai","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.trsl.2019.08.003_bib0057","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12859","article-title":"An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques","volume":"7","author":"Fredman","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2019.08.003_bib0058","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/CIRCRESAHA.116.309492","article-title":"Resolving lipid mediators Maresin 1 and Resolvin D2 prevent atheroprogression in mice","volume":"119","author":"Viola","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2019.08.003_bib0059","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2353\/ajpath.2010.091082","article-title":"Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis","volume":"177","author":"Ho","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0060","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1096\/fj.14-265363","article-title":"Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice","volume":"29","author":"Akagi","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2019.08.003_bib0061","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1096\/fj.201800173R","article-title":"Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration","volume":"32","author":"Liu","year":"2018","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.trsl.2019.08.003_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2016.01.030","article-title":"Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury","volume":"65","author":"Wu","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.trsl.2019.08.003_bib0063","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/JLB.3HI0517-206RR","article-title":"Frontline science: specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome","volume":"105","author":"Lopategi","year":"2018","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0064","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1164\/rccm.201604-0892OC","article-title":"NLRP3 inflammasome deficiency protects against microbial sepsis via increased lipoxin B4 synthesis","volume":"196","author":"Lee","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2019.08.003_bib0065","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1194\/jlr.M072587","article-title":"NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury","volume":"58","author":"Li","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2019.08.003_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2438247","article-title":"Maresin 1 mitigates high glucose-induced mouse glomerular mesangial cell injury by inhibiting inflammation and fibrosis","volume":"2017","author":"Tang","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.trsl.2019.08.003_bib0067","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev-biophys-060414-034248","article-title":"Mechanisms of autophagy","volume":"44","author":"Noda","year":"2015","journal-title":"Annu Rev Biophys."},{"key":"10.1016\/j.trsl.2019.08.003_bib0068","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00018-011-0865-5","article-title":"Microautophagy: lesser-known self-eating","volume":"69","author":"Li","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.trsl.2019.08.003_bib0069","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/cr.2013.153","article-title":"Chaperone-mediated autophagy: roles in disease and aging","volume":"24","author":"Cuervo","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.trsl.2019.08.003_bib0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.08.003_bib0071","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni.2215","article-title":"Activation of autophagy by inflammatory signals limits IL-1\u03b2 production by targeting ubiquitinated inflammasomes for destruction","volume":"13","author":"Shi","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0072","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cmet.2012.02.011","article-title":"Autophagy links inflammasomes to atherosclerotic progression","volume":"15","author":"Razani","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.trsl.2019.08.003_bib0073","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/01.RES.83.4.378","article-title":"Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal","volume":"83","author":"Kockx","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2019.08.003_bib0074","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1161\/01.ATV.0000146266.65820.a1","article-title":"7-Ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells","volume":"24","author":"Martinet","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0075","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCRESAHA.108.188318","article-title":"Autophagy in atherosclerosis","volume":"104","author":"Martinet","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2019.08.003_bib0076","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/15548627.2017.1280221","article-title":"Transgenic rescue of Atg5-null mice from neonatal lethality with neuron-specific expression of ATG5: systemic analysis of adult Atg5-deficient mice","volume":"13","author":"Yoshii","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.trsl.2019.08.003_bib0077","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.ajpath.2018.08.014","article-title":"Protective role of autophagy in NLRP3 inflammasome activation and medial thickening of mouse coronary arteries","volume":"188","author":"Yuan","year":"2018","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0078","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.bbadis.2017.12.027","article-title":"Sirtuin 3-induced macrophage autophagy in regulating NLRP3 inflammasome activation","volume":"1864","author":"Liu","year":"2018","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Basis Dis"},{"key":"10.1016\/j.trsl.2019.08.003_bib0079","article-title":"Trimethylamine\u2010N\u2010oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3\u2010SOD2\u2010mtROS signaling pathway","volume":"6","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.trsl.2019.08.003_bib0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47610-w","article-title":"Miltefosine increases macrophage cholesterol efflux and inhibits NLRP3-inflammasome assembly and IL-1beta release","volume":"9","author":"Iacano","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2019.08.003_bib0081","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrd.2017.22","article-title":"Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles","volume":"16","author":"Galluzzi","year":"2017","journal-title":"Nat Rev Drug Discov."},{"key":"10.1016\/j.trsl.2019.08.003_bib0082","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/cr.2010.135","article-title":"Chemical probing reveals insights into the signaling mechanism of inflammasome activation","volume":"20","author":"Gong","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.trsl.2019.08.003_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2017.08.017","article-title":"NLRP3 phosphorylation is an essential priming event for inflammasome activation","volume":"68","author":"Song","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.trsl.2019.08.003_bib0084","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.4049\/jimmunol.1301974","article-title":"Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function","volume":"192","author":"Ghonime","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0085","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1074\/jbc.M412820200","article-title":"NF-\u03baB- and C\/EBP\u03b2-driven interleukin-1\u03b2 gene expression and PAK1-mediated Caspase-1 activation play essential roles in interleukin-1\u03b2 release from helicobacter pylorilipo polysaccharide-stimulated macrophages","volume":"280","author":"Basak","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2019.08.003_bib0086","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2019.08.003_bib0087","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1038\/ncomms5977","article-title":"IKK\u03b1 negatively regulates ASC-dependent inflammasome activation","volume":"5","author":"Martin","year":"2014","journal-title":"Nat Commun."},{"key":"10.1016\/j.trsl.2019.08.003_bib0088","doi-asserted-by":"crossref","first-page":"13727","DOI":"10.1038\/ncomms13727","article-title":"The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3","volume":"7","author":"Song","year":"2016","journal-title":"Nat Commun."},{"key":"10.1016\/j.trsl.2019.08.003_bib0089","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.4049\/jimmunol.1700184","article-title":"ARIH2 ubiquitinates NLRP3 and negatively regulates NLRP3 inflammasome activation in macrophages","volume":"199","author":"Kawashima","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2012.11.009","article-title":"Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity","volume":"49","author":"Py","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.trsl.2019.08.003_bib0091","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ni.3538","article-title":"NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations","volume":"17","author":"Mortimer","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2019.08.003_bib0092","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2019.08.003_bib0093","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature11588","article-title":"The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP","volume":"492","author":"Lee","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.08.003_bib0094","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","article-title":"TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading","volume":"14","author":"Pols","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.trsl.2019.08.003_bib0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2019.08.003_bib0096","doi-asserted-by":"crossref","first-page":"39528","DOI":"10.1074\/jbc.M111.278812","article-title":"Crystal structure of NALP3 protein pyrin domain (PYD) and its implications in inflammasome assembly","volume":"286","author":"Bae","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2019.08.003_bib0097","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1172\/JCI83669","article-title":"NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22 [published correction appears in J Clin Invest. 2016;126(11):4388]","volume":"126","author":"Spalinger","year":"2016","journal-title":"J Clin Invest."},{"key":"10.1016\/j.trsl.2019.08.003_bib0098","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.08.003_bib0099","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002128","article-title":"Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome","volume":"4","author":"Mart\u00ednez","year":"2015","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.trsl.2019.08.003_bib0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.atherosclerosis.2018.03.043","article-title":"Corrigendum to: \u201cThe NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation\u201d [Atherosclerosis. 2018;269:262\u2013271]","volume":"273","author":"Mart\u00ednez","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.trsl.2019.08.003_bib0101","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524419301665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524419301665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:39:46Z","timestamp":1761827986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524419301665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":101,"alternative-id":["S1931524419301665"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2019.08.003","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atherothrombosis and the NLRP3 inflammasome \u2013 endogenous mechanisms of inhibition","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2019.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}